CA
HQL

Cetera Advisors’s abrdn Life Sciences Investors HQL Stock Holding History

Cetera Advisors’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$1.93M Buy
+141,526
New +$1.96M 0.02% 838

Other funds holding HQL

SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AIA
Absolute Investment Advisers Rosemary Beach, Florida $852M AUM 0.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
KIM
Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Cetera Advisors's HQL Position: Q1 2024 in Review

Cetera Advisors opened a new position in abrdn Life Sciences Investors (HQL) in Q1 2024: 141,526 shares worth $1.93M. The stake represents 0.02% of the portfolio and ranks #838 among its holdings.

79 funds tracked by Wall St. Rank hold HQL as of Q1 2024.

  • Cetera Advisors held 141,526 shares of abrdn Life Sciences Investors worth $1.93M as of Q1 2024.
  • abrdn Life Sciences Investors was a new Cetera Advisors position in Q1 2024.
  • abrdn Life Sciences Investors made up 0.02% of Cetera Advisors's portfolio in Q1 2024, its #838 holding.
  • 79 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.